BioCentury
ARTICLE | Product Development

Two-pronged attack

February 29, 2016 8:00 AM UTC

Oncolytic viruses can stimulate both direct and indirect killing of cancer cells, as illustrated by Imlygic talimogene laherparepvec (T-Vec) from Amgen Inc. (NASDAQ:AMGN). Imlygic is a modified herpes...